Nina Kostevsek Selected Research

L 377202

1/2022	Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
1/2019	Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina Kostevsek Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
1	Hyperthermia 01/2022

Drug/Important Bio-Agent (IBA)

2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	ProdrugsIBA 01/2022 - 01/2019
2	L 377202IBA 01/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
1	Biological ProductsIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022

Therapy/Procedure

1	Therapeutics 01/2022
1	Castration 01/2019